28239461|t|Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers
28239461|a|The aim of this study was to validate previously described diagnostic and prognostic microRNA expression profiles in tissue samples from patients with pancreatic cancer and other periampullary cancers. Expression of 46 selected microRNAs was studied in formalin -fixed paraffin-embedded tissue from patients with resected pancreatic ductal adenocarcinoma (n = 165), ampullary cancer (n=59), duodenal cancer (n = 6), distal common bile duct cancer (n = 21), and gastric cancer (n = 20); chronic pancreatitis (n = 39); and normal pancreas (n = 35). The microRNAs were analyzed by PCR using the Fluidigm platform. Twenty-two microRNAs were significantly differently expressed in patients with pancreatic cancer when compared to healthy controls and chronic pancreatitis patients; 17 miRNAs were upregulated (miR-21-5p, - 23a-3p, - 31-5p, - 34c-5p, - 93-3p, - 135b-3p, - 155-5p, - 186-5p, - 196b-5p, - 203, - 205-5p, - 210, - 222-3p, - 451, - 492, - 614, and miR-622) and 5 were downregulated (miR-122-5p, - 130b-3p, - 216b, - 217, and miR-375). MicroRNAs were grouped into diagnostic indices of varying complexity. Ten microRNAs associated with prognosis were identified (let-7 g, miR-29a-5p, - 34a-5p, - 125a-3p, - 146a-5p, - 187, - 205-5p, - 212-3p, - 222-5p, and miR-450b-5p). Prognostic indices based on differences in expression of 2 different microRNAs were constructed for pancreatic and ampullary cancer combined and separately (30, 5, and 21 indices). The study confirms that pancreatic cancer tissue has a microRNA expression profile that is different from that of other periampullary cancers, chronic pancreatitis, and normal pancreas. We identified prognostic microRNAs and microRNA indices that were associated with shorter overall survival in patients with radically resected pancreatic cancer.
28239461	0	6	Tissue	T024	C0040300
28239461	7	15	MicroRNA	T114,T123	C1101610
28239461	28	38	diagnostic	T201	C1511876
28239461	43	64	prognostic biomarkers	T080	C1514475
28239461	68	76	patients	T101	C0030705
28239461	82	92	resectable	T061	C0015252
28239461	93	125	pancreatic ductal adenocarcinoma	T191	C1335302
28239461	130	151	periampullary cancers	T191	C1335377
28239461	156	159	aim	T078	C1947946
28239461	168	173	study	T062	C2603343
28239461	211	221	diagnostic	T169	C0348026
28239461	226	236	prognostic	T170	C0220901
28239461	237	245	microRNA	T114,T123	C1101610
28239461	246	265	expression profiles	T081	C1956267
28239461	269	275	tissue	T024	C0040300
28239461	289	297	patients	T101	C0030705
28239461	303	320	pancreatic cancer	T191	C0235974
28239461	331	352	periampullary cancers	T191	C1335377
28239461	354	364	Expression	T045	C0017262
28239461	380	389	microRNAs	T114,T123	C1101610
28239461	405	413	formalin	T109,T121,T131	C0949307
28239461	421	445	paraffin-embedded tissue	T024	C1519524
28239461	451	459	patients	T101	C0030705
28239461	465	473	resected	T061	C0015252
28239461	474	506	pancreatic ductal adenocarcinoma	T191	C1335302
28239461	518	534	ampullary cancer	T191	C0262401
28239461	543	558	duodenal cancer	T191	C0541912
28239461	568	574	distal	T082	C0205108
28239461	575	598	common bile duct cancer	T191	C0740277
28239461	613	627	gastric cancer	T191	C0024623
28239461	638	658	chronic pancreatitis	T047	C0149521
28239461	673	688	normal pancreas	T033	C0940731
28239461	703	712	microRNAs	T114,T123	C1101610
28239461	730	733	PCR	T063	C0032520
28239461	744	761	Fluidigm platform	T170	C0282574
28239461	774	783	microRNAs	T114,T123	C1101610
28239461	815	824	expressed	T045	C0017262
28239461	828	836	patients	T101	C0030705
28239461	842	859	pancreatic cancer	T191	C0235974
28239461	877	893	healthy controls	T080	C2986479
28239461	898	918	chronic pancreatitis	T047	C0149521
28239461	919	927	patients	T101	C0030705
28239461	932	938	miRNAs	T114,T123	C1101610
28239461	944	955	upregulated	T044	C0041904
28239461	957	966	miR-21-5p	T028	C1537719
28239461	970	976	23a-3p	T028	C1842758
28239461	980	985	31-5p	T028	C1537742
28239461	989	995	34c-5p	T028	C1537747
28239461	999	1004	93-3p	T028	C1537750
28239461	1008	1015	135b-3p	T028	C1537788
28239461	1019	1025	155-5p	T028	C1537811
28239461	1029	1035	186-5p	T028	C1537820
28239461	1039	1047	196b-5p,	T028	C1537832
28239461	1050	1053	203	T028	C1537841
28239461	1057	1063	205-5p	T114	C4284346
28239461	1067	1070	210	T028	C1537846
28239461	1074	1080	222-3p	T028	C1537860
28239461	1084	1087	451	T028	C1826031
28239461	1091	1094	492	T028	C1826046
28239461	1098	1101	614	T028	C1826193
28239461	1107	1114	miR-622	T028	C1826201
28239461	1127	1140	downregulated	T044	C0013081
28239461	1142	1152	miR-122-5p	T028	C1865068
28239461	1156	1163	130b-3p	T028	C1537780
28239461	1167	1171	216b	T028	C2239687
28239461	1175	1178	217	T028	C1537853
28239461	1184	1191	miR-375	T028	C1537896
28239461	1194	1203	MicroRNAs	T114,T123	C1101610
28239461	1222	1232	diagnostic	T169	C0348026
28239461	1252	1262	complexity	T080	C0439855
28239461	1268	1277	microRNAs	T114,T123	C1101610
28239461	1278	1293	associated with	T080	C0332281
28239461	1294	1303	prognosis	T058	C0033325
28239461	1321	1328	let-7 g	T114,T123	C1621390
28239461	1330	1340	miR-29a-5p	T028	C1835841
28239461	1344	1350	34a-5p	T028	C1537745
28239461	1354	1361	125a-3p	T028	C1537770
28239461	1365	1372	146a-5p	T028	C1826002
28239461	1376	1379	187	T028	C1537821
28239461	1383	1389	205-5p	T114	C4284346
28239461	1393	1399	212-3p	T028	C1537848
28239461	1403	1409	222-5p	T028	C1537860
28239461	1415	1426	miR-450b-5p	T028	C2239697
28239461	1429	1447	Prognostic indices	T081	C0033326
28239461	1472	1482	expression	T045	C0017262
28239461	1498	1507	microRNAs	T114,T123	C1101610
28239461	1529	1539	pancreatic	T191	C0235974
28239461	1544	1560	ampullary cancer	T191	C0262401
28239461	1614	1619	study	T062	C2603343
28239461	1634	1651	pancreatic cancer	T191	C0235974
28239461	1652	1658	tissue	T024	C0040300
28239461	1665	1673	microRNA	T114,T123	C1101610
28239461	1674	1692	expression profile	T081	C1956267
28239461	1730	1751	periampullary cancers	T191	C1335377
28239461	1753	1773	chronic pancreatitis	T047	C0149521
28239461	1779	1794	normal pancreas	T033	C0940731
28239461	1810	1820	prognostic	T170	C0220901
28239461	1821	1830	microRNAs	T114,T123	C1101610
28239461	1835	1843	microRNA	T114,T123	C1101610
28239461	1862	1877	associated with	T080	C0332281
28239461	1886	1902	overall survival	T081	C4086681
28239461	1906	1914	patients	T101	C0030705
28239461	1930	1938	resected	T061	C0015252
28239461	1939	1956	pancreatic cancer	T191	C0235974